Bruns–Garland syndrome precipitated by anti-tuberculous therapy in a patient with type 2 diabetes mellitus
DOI:
https://doi.org/10.3126/njn.v19i1.40952Keywords:
Bruns Garland syndrome, Diabetic amyotrophy, Diabetes mellitus, Tuberculosis, Anti-tuberculous therapyAbstract
India has a high prevalence of tuberculosis as well as diabetes mellitus, and both contribute to a major disease burden. Diabetes mellitus increases the risk of tuberculosis. Patients with diabetes are more prone to develop cavitary lesions than non-diabetics. Tuberculosis can worsen the glycemic status of an individual and anti-tuberculous drugs like Rifampicin can interact with oral anti-diabetic drugs, further worsening the glycemic control. This can result in complications related to diabetes, like diabetic amyotrophy. We hereby report the case of a 69-year-old gentleman with diabetes mellitus, who developed uncontrolled blood sugars, leading to Bruns Garland syndrome or diabetic amyotrophy on starting anti-tuberculous therapy for sputum positive pulmonary tuberculosis.
Downloads
82
66
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Nepalese Society of Neurosurgeons (NESON)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.